nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0952	0.224	CbGbCtD
Promethazine—CYP2C9—Progesterone—uterine cancer	0.063	0.148	CbGbCtD
Promethazine—ABCB1—Progesterone—uterine cancer	0.0612	0.144	CbGbCtD
Promethazine—CYP2D6—Progesterone—uterine cancer	0.0576	0.135	CbGbCtD
Promethazine—ABCB1—Dactinomycin—uterine cancer	0.0485	0.114	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—uterine cancer	0.0364	0.0856	CbGbCtD
Promethazine—ABCB1—Etoposide—uterine cancer	0.0274	0.0643	CbGbCtD
Promethazine—CHRM3—ureter—uterine cancer	0.0198	0.111	CbGeAlD
Promethazine—ABCB1—Doxorubicin—uterine cancer	0.0187	0.0439	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—uterine cancer	0.0176	0.0413	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—uterine cancer	0.0142	0.0799	CbGeAlD
Promethazine—CALM2—semen—uterine cancer	0.00901	0.0506	CbGeAlD
Promethazine—CALM1—semen—uterine cancer	0.00897	0.0503	CbGeAlD
Promethazine—CALM2—oviduct—uterine cancer	0.00661	0.0371	CbGeAlD
Promethazine—CALM2—artery—uterine cancer	0.00438	0.0246	CbGeAlD
Promethazine—CALM1—artery—uterine cancer	0.00436	0.0244	CbGeAlD
Promethazine—CHRM3—exocrine gland—uterine cancer	0.0039	0.0219	CbGeAlD
Promethazine—CALM2—exocrine gland—uterine cancer	0.00382	0.0214	CbGeAlD
Promethazine—CALM1—exocrine gland—uterine cancer	0.0038	0.0213	CbGeAlD
Promethazine—CHRM5—epithelium—uterine cancer	0.00303	0.017	CbGeAlD
Promethazine—CALM3—myometrium—uterine cancer	0.00269	0.0151	CbGeAlD
Promethazine—HTR2A—artery—uterine cancer	0.00265	0.0149	CbGeAlD
Promethazine—Nasal congestion—Progesterone—uterine cancer	0.00233	0.00941	CcSEcCtD
Promethazine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00919	CcSEcCtD
Promethazine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00897	CcSEcCtD
Promethazine—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.0088	CcSEcCtD
Promethazine—Diplopia—Progesterone—uterine cancer	0.00212	0.00857	CcSEcCtD
Promethazine—CALM2—myometrium—uterine cancer	0.00211	0.0119	CbGeAlD
Promethazine—CALM1—myometrium—uterine cancer	0.00211	0.0118	CbGeAlD
Promethazine—CALM3—uterine cervix—uterine cancer	0.0021	0.0118	CbGeAlD
Promethazine—CALM3—smooth muscle tissue—uterine cancer	0.00204	0.0114	CbGeAlD
Promethazine—Irritability—Progesterone—uterine cancer	0.00203	0.00818	CcSEcCtD
Promethazine—CALM3—decidua—uterine cancer	0.002	0.0112	CbGeAlD
Promethazine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00194	0.00783	CcSEcCtD
Promethazine—Necrosis—Etoposide—uterine cancer	0.00191	0.00769	CcSEcCtD
Promethazine—CALM3—endometrium—uterine cancer	0.0019	0.0106	CbGeAlD
Promethazine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00741	CcSEcCtD
Promethazine—Asthma—Progesterone—uterine cancer	0.00183	0.00741	CcSEcCtD
Promethazine—CALM3—mammalian vulva—uterine cancer	0.00183	0.0103	CbGeAlD
Promethazine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00738	CcSEcCtD
Promethazine—Apnoea—Etoposide—uterine cancer	0.00176	0.00712	CcSEcCtD
Promethazine—CALM3—uterus—uterine cancer	0.00175	0.0098	CbGeAlD
Promethazine—Phlebitis—Dactinomycin—uterine cancer	0.00174	0.00703	CcSEcCtD
Promethazine—Sensory loss—Etoposide—uterine cancer	0.00173	0.00697	CcSEcCtD
Promethazine—Extravasation—Etoposide—uterine cancer	0.00171	0.00692	CcSEcCtD
Promethazine—Pain—Carboplatin—uterine cancer	0.0017	0.00686	CcSEcCtD
Promethazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00671	CcSEcCtD
Promethazine—CALM2—epithelium—uterine cancer	0.00166	0.00931	CbGeAlD
Promethazine—CALM1—epithelium—uterine cancer	0.00165	0.00927	CbGeAlD
Promethazine—CALM2—uterine cervix—uterine cancer	0.00165	0.00923	CbGeAlD
Promethazine—CALM1—uterine cervix—uterine cancer	0.00164	0.00919	CbGeAlD
Promethazine—Drowsiness—Progesterone—uterine cancer	0.00164	0.0066	CcSEcCtD
Promethazine—CHRM3—smooth muscle tissue—uterine cancer	0.00163	0.00917	CbGeAlD
Promethazine—Depression—Progesterone—uterine cancer	0.00163	0.00659	CcSEcCtD
Promethazine—CALM2—smooth muscle tissue—uterine cancer	0.0016	0.00897	CbGeAlD
Promethazine—Jaundice—Progesterone—uterine cancer	0.00159	0.00644	CcSEcCtD
Promethazine—CALM1—smooth muscle tissue—uterine cancer	0.00159	0.00893	CbGeAlD
Promethazine—CHRM3—renal system—uterine cancer	0.00157	0.00882	CbGeAlD
Promethazine—CALM2—decidua—uterine cancer	0.00157	0.0088	CbGeAlD
Promethazine—CALM1—decidua—uterine cancer	0.00156	0.00876	CbGeAlD
Promethazine—ADRA1A—epithelium—uterine cancer	0.00156	0.00874	CbGeAlD
Promethazine—Venous thrombosis—Epirubicin—uterine cancer	0.00155	0.00627	CcSEcCtD
Promethazine—CALM2—renal system—uterine cancer	0.00154	0.00864	CbGeAlD
Promethazine—HRH1—myometrium—uterine cancer	0.00154	0.00861	CbGeAlD
Promethazine—CALM1—renal system—uterine cancer	0.00153	0.0086	CbGeAlD
Promethazine—CALM2—endometrium—uterine cancer	0.00149	0.00835	CbGeAlD
Promethazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00598	CcSEcCtD
Promethazine—CALM1—endometrium—uterine cancer	0.00148	0.00831	CbGeAlD
Promethazine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00597	CcSEcCtD
Promethazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00583	CcSEcCtD
Promethazine—ADRA1A—renal system—uterine cancer	0.00144	0.0081	CbGeAlD
Promethazine—CALM2—mammalian vulva—uterine cancer	0.00144	0.00808	CbGeAlD
Promethazine—Venous thrombosis—Doxorubicin—uterine cancer	0.00144	0.0058	CcSEcCtD
Promethazine—CALM1—mammalian vulva—uterine cancer	0.00143	0.00804	CbGeAlD
Promethazine—CALM3—female gonad—uterine cancer	0.00143	0.00802	CbGeAlD
Promethazine—CALM3—vagina—uterine cancer	0.00142	0.00797	CbGeAlD
Promethazine—CHRM1—female reproductive system—uterine cancer	0.00141	0.0079	CbGeAlD
Promethazine—CALM2—uterus—uterine cancer	0.00137	0.0077	CbGeAlD
Promethazine—Tinnitus—Progesterone—uterine cancer	0.00137	0.00553	CcSEcCtD
Promethazine—CALM1—uterus—uterine cancer	0.00137	0.00766	CbGeAlD
Promethazine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00547	CcSEcCtD
Promethazine—Erythema—Progesterone—uterine cancer	0.00128	0.00516	CcSEcCtD
Promethazine—Phlebitis—Etoposide—uterine cancer	0.00126	0.00509	CcSEcCtD
Promethazine—CHRM3—female reproductive system—uterine cancer	0.00126	0.00707	CbGeAlD
Promethazine—Tension—Progesterone—uterine cancer	0.00125	0.00506	CcSEcCtD
Promethazine—Nervousness—Progesterone—uterine cancer	0.00124	0.00501	CcSEcCtD
Promethazine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00501	CcSEcCtD
Promethazine—CALM2—female reproductive system—uterine cancer	0.00123	0.00692	CbGeAlD
Promethazine—Swelling—Etoposide—uterine cancer	0.00123	0.00497	CcSEcCtD
Promethazine—Muscle spasms—Progesterone—uterine cancer	0.00123	0.00496	CcSEcCtD
Promethazine—CALM1—female reproductive system—uterine cancer	0.00123	0.00689	CbGeAlD
Promethazine—Paralysis—Epirubicin—uterine cancer	0.00121	0.00487	CcSEcCtD
Promethazine—HRH1—epithelium—uterine cancer	0.00121	0.00676	CbGeAlD
Promethazine—Vision blurred—Progesterone—uterine cancer	0.0012	0.00486	CcSEcCtD
Promethazine—Tremor—Progesterone—uterine cancer	0.0012	0.00484	CcSEcCtD
Promethazine—HRH1—uterine cervix—uterine cancer	0.00119	0.0067	CbGeAlD
Promethazine—HRH1—smooth muscle tissue—uterine cancer	0.00116	0.00652	CbGeAlD
Promethazine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00468	CcSEcCtD
Promethazine—CHRM3—female gonad—uterine cancer	0.00115	0.00643	CbGeAlD
Promethazine—Syncope—Progesterone—uterine cancer	0.00115	0.00463	CcSEcCtD
Promethazine—CYP2B6—renal system—uterine cancer	0.00114	0.00642	CbGeAlD
Promethazine—HRH1—decidua—uterine cancer	0.00114	0.00639	CbGeAlD
Promethazine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00459	CcSEcCtD
Promethazine—Palpitations—Progesterone—uterine cancer	0.00113	0.00456	CcSEcCtD
Promethazine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00454	CcSEcCtD
Promethazine—Loss of consciousness—Progesterone—uterine cancer	0.00112	0.00454	CcSEcCtD
Promethazine—CALM2—female gonad—uterine cancer	0.00112	0.0063	CbGeAlD
Promethazine—CALM1—female gonad—uterine cancer	0.00112	0.00627	CbGeAlD
Promethazine—Paralysis—Doxorubicin—uterine cancer	0.00112	0.00451	CcSEcCtD
Promethazine—CALM2—vagina—uterine cancer	0.00112	0.00626	CbGeAlD
Promethazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.0045	CcSEcCtD
Promethazine—CALM1—vagina—uterine cancer	0.00111	0.00623	CbGeAlD
Promethazine—Convulsion—Progesterone—uterine cancer	0.00111	0.00447	CcSEcCtD
Promethazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00438	CcSEcCtD
Promethazine—Anxiety—Progesterone—uterine cancer	0.00108	0.00438	CcSEcCtD
Promethazine—HRH1—endometrium—uterine cancer	0.00108	0.00606	CbGeAlD
Promethazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00108	0.00436	CcSEcCtD
Promethazine—Necrosis—Epirubicin—uterine cancer	0.00107	0.00431	CcSEcCtD
Promethazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.0043	CcSEcCtD
Promethazine—Dry mouth—Progesterone—uterine cancer	0.00106	0.0043	CcSEcCtD
Promethazine—Abscess—Epirubicin—uterine cancer	0.00106	0.00428	CcSEcCtD
Promethazine—Confusional state—Progesterone—uterine cancer	0.00105	0.00425	CcSEcCtD
Promethazine—HRH1—mammalian vulva—uterine cancer	0.00105	0.00587	CbGeAlD
Promethazine—Oedema—Progesterone—uterine cancer	0.00104	0.00421	CcSEcCtD
Promethazine—Anaphylactic shock—Progesterone—uterine cancer	0.00104	0.00421	CcSEcCtD
Promethazine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00419	CcSEcCtD
Promethazine—Shock—Progesterone—uterine cancer	0.00103	0.00414	CcSEcCtD
Promethazine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00413	CcSEcCtD
Promethazine—Tachycardia—Progesterone—uterine cancer	0.00102	0.00411	CcSEcCtD
Promethazine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00411	CcSEcCtD
Promethazine—HTR2A—epithelium—uterine cancer	0.00101	0.00565	CbGeAlD
Promethazine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00405	CcSEcCtD
Promethazine—Necrosis—Doxorubicin—uterine cancer	0.000988	0.00399	CcSEcCtD
Promethazine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000982	0.00397	CcSEcCtD
Promethazine—Abscess—Doxorubicin—uterine cancer	0.00098	0.00396	CcSEcCtD
Promethazine—Delirium—Epirubicin—uterine cancer	0.000975	0.00394	CcSEcCtD
Promethazine—Hypotension—Progesterone—uterine cancer	0.000975	0.00394	CcSEcCtD
Promethazine—HTR2A—smooth muscle tissue—uterine cancer	0.00097	0.00544	CbGeAlD
Promethazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00389	CcSEcCtD
Promethazine—Extravasation—Epirubicin—uterine cancer	0.000961	0.00388	CcSEcCtD
Promethazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.000954	0.00385	CcSEcCtD
Promethazine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00385	CcSEcCtD
Promethazine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00382	CcSEcCtD
Promethazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00382	CcSEcCtD
Promethazine—Insomnia—Progesterone—uterine cancer	0.000943	0.00381	CcSEcCtD
Promethazine—HTR2A—renal system—uterine cancer	0.000934	0.00524	CbGeAlD
Promethazine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00376	CcSEcCtD
Promethazine—Somnolence—Progesterone—uterine cancer	0.000927	0.00374	CcSEcCtD
Promethazine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00374	CcSEcCtD
Promethazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00373	CcSEcCtD
Promethazine—CALM3—lymph node—uterine cancer	0.000919	0.00515	CbGeAlD
Promethazine—Dyspepsia—Progesterone—uterine cancer	0.000918	0.00371	CcSEcCtD
Promethazine—CYP2B6—female reproductive system—uterine cancer	0.000917	0.00514	CbGeAlD
Promethazine—CYP2C9—female reproductive system—uterine cancer	0.000908	0.00509	CbGeAlD
Promethazine—Decreased appetite—Progesterone—uterine cancer	0.000907	0.00366	CcSEcCtD
Promethazine—Erythema—Dactinomycin—uterine cancer	0.000903	0.00365	CcSEcCtD
Promethazine—Delirium—Doxorubicin—uterine cancer	0.000902	0.00364	CcSEcCtD
Promethazine—Fatigue—Progesterone—uterine cancer	0.000899	0.00363	CcSEcCtD
Promethazine—HRH1—female reproductive system—uterine cancer	0.000895	0.00502	CbGeAlD
Promethazine—Dyskinesia—Epirubicin—uterine cancer	0.000892	0.0036	CcSEcCtD
Promethazine—Constipation—Progesterone—uterine cancer	0.000892	0.0036	CcSEcCtD
Promethazine—Pain—Progesterone—uterine cancer	0.000892	0.0036	CcSEcCtD
Promethazine—Extravasation—Doxorubicin—uterine cancer	0.000889	0.00359	CcSEcCtD
Promethazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00357	CcSEcCtD
Promethazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000883	0.00356	CcSEcCtD
Promethazine—Feeling abnormal—Progesterone—uterine cancer	0.000859	0.00347	CcSEcCtD
Promethazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.00345	CcSEcCtD
Promethazine—Coordination abnormal—Epirubicin—uterine cancer	0.000854	0.00345	CcSEcCtD
Promethazine—CYP2D6—renal system—uterine cancer	0.000851	0.00477	CbGeAlD
Promethazine—ABCB1—myometrium—uterine cancer	0.00084	0.00471	CbGeAlD
Promethazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00339	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—uterine cancer	0.000833	0.00337	CcSEcCtD
Promethazine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00336	CcSEcCtD
Promethazine—CYP2B6—vagina—uterine cancer	0.000829	0.00465	CbGeAlD
Promethazine—Dermatitis contact—Epirubicin—uterine cancer	0.000828	0.00335	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—uterine cancer	0.000825	0.00333	CcSEcCtD
Promethazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000822	0.00332	CcSEcCtD
Promethazine—Jaundice—Etoposide—uterine cancer	0.000815	0.00329	CcSEcCtD
Promethazine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000815	0.00329	CcSEcCtD
Promethazine—HRH1—female gonad—uterine cancer	0.000815	0.00457	CbGeAlD
Promethazine—HRH1—vagina—uterine cancer	0.00081	0.00454	CbGeAlD
Promethazine—Leukopenia—Dactinomycin—uterine cancer	0.000809	0.00327	CcSEcCtD
Promethazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00326	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—uterine cancer	0.00079	0.00319	CcSEcCtD
Promethazine—Aplastic anaemia—Epirubicin—uterine cancer	0.000787	0.00318	CcSEcCtD
Promethazine—Agranulocytosis—Etoposide—uterine cancer	0.000781	0.00315	CcSEcCtD
Promethazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00315	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—uterine cancer	0.000771	0.00311	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—uterine cancer	0.000767	0.0031	CcSEcCtD
Promethazine—Coma—Epirubicin—uterine cancer	0.000766	0.00309	CcSEcCtD
Promethazine—Asthenia—Progesterone—uterine cancer	0.000748	0.00302	CcSEcCtD
Promethazine—HTR2A—female reproductive system—uterine cancer	0.000748	0.0042	CbGeAlD
Promethazine—Pruritus—Progesterone—uterine cancer	0.000738	0.00298	CcSEcCtD
Promethazine—Oedema—Dactinomycin—uterine cancer	0.000737	0.00298	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—uterine cancer	0.000728	0.00294	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000722	0.00291	CcSEcCtD
Promethazine—CALM2—lymph node—uterine cancer	0.000721	0.00405	CbGeAlD
Promethazine—CALM1—lymph node—uterine cancer	0.000718	0.00403	CbGeAlD
Promethazine—Diarrhoea—Progesterone—uterine cancer	0.000714	0.00288	CcSEcCtD
Promethazine—Coma—Doxorubicin—uterine cancer	0.000709	0.00286	CcSEcCtD
Promethazine—Phlebitis—Epirubicin—uterine cancer	0.000706	0.00285	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—uterine cancer	0.000703	0.00284	CcSEcCtD
Promethazine—Photosensitivity—Epirubicin—uterine cancer	0.000693	0.0028	CcSEcCtD
Promethazine—Dizziness—Progesterone—uterine cancer	0.00069	0.00279	CcSEcCtD
Promethazine—CYP2D6—female reproductive system—uterine cancer	0.000681	0.00382	CbGeAlD
Promethazine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.00274	CcSEcCtD
Promethazine—HTR2A—vagina—uterine cancer	0.000676	0.00379	CbGeAlD
Promethazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000669	0.0027	CcSEcCtD
Promethazine—ABCB1—epithelium—uterine cancer	0.00066	0.0037	CbGeAlD
Promethazine—Rash—Progesterone—uterine cancer	0.000658	0.00266	CcSEcCtD
Promethazine—Dermatitis—Progesterone—uterine cancer	0.000657	0.00265	CcSEcCtD
Promethazine—ABCB1—uterine cervix—uterine cancer	0.000654	0.00367	CbGeAlD
Promethazine—Phlebitis—Doxorubicin—uterine cancer	0.000654	0.00264	CcSEcCtD
Promethazine—Headache—Progesterone—uterine cancer	0.000653	0.00264	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00065	0.00263	CcSEcCtD
Promethazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00261	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—uterine cancer	0.000641	0.00259	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—uterine cancer	0.000641	0.00259	CcSEcCtD
Promethazine—Fatigue—Dactinomycin—uterine cancer	0.000636	0.00257	CcSEcCtD
Promethazine—Pain—Dactinomycin—uterine cancer	0.00063	0.00255	CcSEcCtD
Promethazine—Muscle spasms—Etoposide—uterine cancer	0.000629	0.00254	CcSEcCtD
Promethazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00252	CcSEcCtD
Promethazine—ABCB1—decidua—uterine cancer	0.000623	0.0035	CbGeAlD
Promethazine—CYP2D6—female gonad—uterine cancer	0.00062	0.00348	CbGeAlD
Promethazine—ABCB1—renal system—uterine cancer	0.000612	0.00343	CbGeAlD
Promethazine—Diplopia—Epirubicin—uterine cancer	0.000609	0.00246	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—uterine cancer	0.000607	0.00245	CcSEcCtD
Promethazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00241	CcSEcCtD
Promethazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000595	0.0024	CcSEcCtD
Promethazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.00239	CcSEcCtD
Promethazine—ABCB1—endometrium—uterine cancer	0.000591	0.00332	CbGeAlD
Promethazine—Leukopenia—Etoposide—uterine cancer	0.000585	0.00236	CcSEcCtD
Promethazine—Loss of consciousness—Etoposide—uterine cancer	0.000575	0.00232	CcSEcCtD
Promethazine—ABCB1—mammalian vulva—uterine cancer	0.000572	0.00321	CbGeAlD
Promethazine—Convulsion—Etoposide—uterine cancer	0.000566	0.00229	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—uterine cancer	0.000563	0.00227	CcSEcCtD
Promethazine—ABCB1—uterus—uterine cancer	0.000545	0.00306	CbGeAlD
Promethazine—Confusional state—Etoposide—uterine cancer	0.000538	0.00217	CcSEcCtD
Promethazine—Anaphylactic shock—Etoposide—uterine cancer	0.000534	0.00215	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—uterine cancer	0.000529	0.00214	CcSEcCtD
Promethazine—Asthma—Epirubicin—uterine cancer	0.000526	0.00212	CcSEcCtD
Promethazine—HRH1—lymph node—uterine cancer	0.000524	0.00294	CbGeAlD
Promethazine—Thrombocytopenia—Etoposide—uterine cancer	0.000522	0.00211	CcSEcCtD
Promethazine—Tachycardia—Etoposide—uterine cancer	0.000521	0.0021	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—uterine cancer	0.000504	0.00204	CcSEcCtD
Promethazine—Hypotension—Etoposide—uterine cancer	0.000499	0.00201	CcSEcCtD
Promethazine—ABCB1—female reproductive system—uterine cancer	0.00049	0.00275	CbGeAlD
Promethazine—Asthma—Doxorubicin—uterine cancer	0.000487	0.00197	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00048	0.00194	CcSEcCtD
Promethazine—Somnolence—Etoposide—uterine cancer	0.000474	0.00192	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—uterine cancer	0.000469	0.00189	CcSEcCtD
Promethazine—Rash—Dactinomycin—uterine cancer	0.000465	0.00188	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—uterine cancer	0.000464	0.00187	CcSEcCtD
Promethazine—Fatigue—Etoposide—uterine cancer	0.00046	0.00186	CcSEcCtD
Promethazine—Jaundice—Epirubicin—uterine cancer	0.000457	0.00185	CcSEcCtD
Promethazine—Constipation—Etoposide—uterine cancer	0.000456	0.00184	CcSEcCtD
Promethazine—Pain—Etoposide—uterine cancer	0.000456	0.00184	CcSEcCtD
Promethazine—ABCB1—female gonad—uterine cancer	0.000446	0.0025	CbGeAlD
Promethazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000444	0.00179	CcSEcCtD
Promethazine—ABCB1—vagina—uterine cancer	0.000443	0.00249	CbGeAlD
Promethazine—Feeling abnormal—Etoposide—uterine cancer	0.00044	0.00178	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—uterine cancer	0.000438	0.00177	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—uterine cancer	0.000434	0.00175	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—uterine cancer	0.000429	0.00173	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—uterine cancer	0.000423	0.00171	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000405	0.00164	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—uterine cancer	0.000397	0.0016	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—uterine cancer	0.000392	0.00159	CcSEcCtD
Promethazine—Asthenia—Etoposide—uterine cancer	0.000383	0.00155	CcSEcCtD
Promethazine—Pruritus—Etoposide—uterine cancer	0.000377	0.00152	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—uterine cancer	0.000376	0.00152	CcSEcCtD
Promethazine—Erythema—Epirubicin—uterine cancer	0.000366	0.00148	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—uterine cancer	0.000365	0.00147	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—uterine cancer	0.000363	0.00147	CcSEcCtD
Promethazine—Tension—Epirubicin—uterine cancer	0.00036	0.00145	CcSEcCtD
Promethazine—Nervousness—Epirubicin—uterine cancer	0.000356	0.00144	CcSEcCtD
Promethazine—Dizziness—Etoposide—uterine cancer	0.000353	0.00142	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—uterine cancer	0.000352	0.00142	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—uterine cancer	0.000348	0.00141	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—uterine cancer	0.000345	0.00139	CcSEcCtD
Promethazine—Erythema—Doxorubicin—uterine cancer	0.000339	0.00137	CcSEcCtD
Promethazine—Agitation—Epirubicin—uterine cancer	0.000337	0.00136	CcSEcCtD
Promethazine—Rash—Etoposide—uterine cancer	0.000336	0.00136	CcSEcCtD
Promethazine—Dermatitis—Etoposide—uterine cancer	0.000336	0.00136	CcSEcCtD
Promethazine—Headache—Etoposide—uterine cancer	0.000334	0.00135	CcSEcCtD
Promethazine—Tension—Doxorubicin—uterine cancer	0.000333	0.00134	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—uterine cancer	0.000329	0.00133	CcSEcCtD
Promethazine—Syncope—Epirubicin—uterine cancer	0.000329	0.00133	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—uterine cancer	0.000328	0.00132	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—uterine cancer	0.000326	0.00132	CcSEcCtD
Promethazine—Palpitations—Epirubicin—uterine cancer	0.000324	0.00131	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—uterine cancer	0.000322	0.0013	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—uterine cancer	0.00032	0.00129	CcSEcCtD
Promethazine—Convulsion—Epirubicin—uterine cancer	0.000318	0.00128	CcSEcCtD
Promethazine—Agitation—Doxorubicin—uterine cancer	0.000312	0.00126	CcSEcCtD
Promethazine—Anxiety—Epirubicin—uterine cancer	0.000311	0.00126	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—uterine cancer	0.000305	0.00123	CcSEcCtD
Promethazine—Syncope—Doxorubicin—uterine cancer	0.000304	0.00123	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—uterine cancer	0.000304	0.00123	CcSEcCtD
Promethazine—Confusional state—Epirubicin—uterine cancer	0.000302	0.00122	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—uterine cancer	0.0003	0.00121	CcSEcCtD
Promethazine—Oedema—Epirubicin—uterine cancer	0.000299	0.00121	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—uterine cancer	0.000299	0.00121	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—uterine cancer	0.000298	0.0012	CcSEcCtD
Promethazine—Shock—Epirubicin—uterine cancer	0.000294	0.00119	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—uterine cancer	0.000294	0.00119	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000293	0.00118	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—uterine cancer	0.000292	0.00118	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—uterine cancer	0.000288	0.00116	CcSEcCtD
Promethazine—ABCB1—lymph node—uterine cancer	0.000287	0.00161	CbGeAlD
Promethazine—Dry mouth—Doxorubicin—uterine cancer	0.000282	0.00114	CcSEcCtD
Promethazine—Hypotension—Epirubicin—uterine cancer	0.000279	0.00113	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—uterine cancer	0.000279	0.00113	CcSEcCtD
Promethazine—Oedema—Doxorubicin—uterine cancer	0.000277	0.00112	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000277	0.00112	CcSEcCtD
Promethazine—Shock—Doxorubicin—uterine cancer	0.000272	0.0011	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000271	0.00109	CcSEcCtD
Promethazine—Insomnia—Epirubicin—uterine cancer	0.000271	0.00109	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—uterine cancer	0.00027	0.00109	CcSEcCtD
Promethazine—Somnolence—Epirubicin—uterine cancer	0.000266	0.00107	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—uterine cancer	0.000263	0.00106	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—uterine cancer	0.00026	0.00105	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—uterine cancer	0.000259	0.00104	CcSEcCtD
Promethazine—Fatigue—Epirubicin—uterine cancer	0.000258	0.00104	CcSEcCtD
Promethazine—Constipation—Epirubicin—uterine cancer	0.000256	0.00103	CcSEcCtD
Promethazine—Pain—Epirubicin—uterine cancer	0.000256	0.00103	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—uterine cancer	0.00025	0.00101	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—uterine cancer	0.000246	0.000995	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—uterine cancer	0.000246	0.000994	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—uterine cancer	0.000244	0.000984	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—uterine cancer	0.000241	0.000971	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—uterine cancer	0.000239	0.000964	CcSEcCtD
Promethazine—Pain—Doxorubicin—uterine cancer	0.000237	0.000956	CcSEcCtD
Promethazine—Constipation—Doxorubicin—uterine cancer	0.000237	0.000956	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—uterine cancer	0.000228	0.000921	CcSEcCtD
Promethazine—Asthenia—Epirubicin—uterine cancer	0.000215	0.000867	CcSEcCtD
Promethazine—Pruritus—Epirubicin—uterine cancer	0.000212	0.000855	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—uterine cancer	0.000205	0.000826	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—uterine cancer	0.000199	0.000802	CcSEcCtD
Promethazine—Dizziness—Epirubicin—uterine cancer	0.000198	0.000799	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—uterine cancer	0.000196	0.000791	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—uterine cancer	0.000189	0.000765	CcSEcCtD
Promethazine—Rash—Epirubicin—uterine cancer	0.000189	0.000762	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—uterine cancer	0.000188	0.000761	CcSEcCtD
Promethazine—Headache—Epirubicin—uterine cancer	0.000187	0.000757	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—uterine cancer	0.000183	0.000739	CcSEcCtD
Promethazine—Rash—Doxorubicin—uterine cancer	0.000174	0.000705	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—uterine cancer	0.000174	0.000704	CcSEcCtD
Promethazine—Headache—Doxorubicin—uterine cancer	0.000173	0.0007	CcSEcCtD
Promethazine—CALM2—Immune System—EP300—uterine cancer	1.26e-05	8.46e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	1.26e-05	8.46e-05	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—AKT1—uterine cancer	1.25e-05	8.43e-05	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—AKT1—uterine cancer	1.25e-05	8.43e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CTNNB1—uterine cancer	1.25e-05	8.4e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—CTNNB1—uterine cancer	1.25e-05	8.4e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	1.24e-05	8.38e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	1.24e-05	8.38e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.24e-05	8.36e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	1.24e-05	8.35e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCL2—uterine cancer	1.24e-05	8.34e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ERBB2—uterine cancer	1.24e-05	8.33e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ERBB2—uterine cancer	1.23e-05	8.3e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	1.22e-05	8.22e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	1.22e-05	8.2e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PTEN—uterine cancer	1.22e-05	8.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PTEN—uterine cancer	1.22e-05	8.19e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—NRAS—uterine cancer	1.21e-05	8.18e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KRAS—uterine cancer	1.2e-05	8.09e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—EP300—uterine cancer	1.2e-05	8.08e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EP300—uterine cancer	1.2e-05	8.07e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	1.2e-05	8.07e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCL2—uterine cancer	1.2e-05	8.07e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCL2—uterine cancer	1.2e-05	8.07e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	1.19e-05	8.02e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.18e-05	7.95e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	1.18e-05	7.94e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.18e-05	7.93e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—NRAS—uterine cancer	1.18e-05	7.91e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—NRAS—uterine cancer	1.18e-05	7.91e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CXCL8—uterine cancer	1.17e-05	7.9e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	1.17e-05	7.89e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	1.17e-05	7.88e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CXCL8—uterine cancer	1.17e-05	7.88e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.17e-05	7.87e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HRAS—uterine cancer	1.17e-05	7.85e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HRAS—uterine cancer	1.16e-05	7.82e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EP300—uterine cancer	1.16e-05	7.81e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EP300—uterine cancer	1.16e-05	7.81e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	1.16e-05	7.8e-05	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	1.16e-05	7.8e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	1.15e-05	7.78e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	1.15e-05	7.76e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	1.15e-05	7.75e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KRAS—uterine cancer	1.15e-05	7.75e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.15e-05	7.74e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	1.15e-05	7.73e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	1.15e-05	7.72e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—KRAS—uterine cancer	1.14e-05	7.71e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	1.14e-05	7.69e-05	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	1.14e-05	7.67e-05	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.14e-05	7.66e-05	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	1.13e-05	7.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	1.13e-05	7.62e-05	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	1.13e-05	7.61e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	1.13e-05	7.6e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—NRAS—uterine cancer	1.12e-05	7.55e-05	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	1.12e-05	7.51e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—KRAS—uterine cancer	1.11e-05	7.46e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—KRAS—uterine cancer	1.11e-05	7.46e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	1.11e-05	7.45e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	1.1e-05	7.43e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	1.09e-05	7.33e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	1.09e-05	7.31e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—NRAS—uterine cancer	1.09e-05	7.31e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—NRAS—uterine cancer	1.09e-05	7.31e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	1.08e-05	7.29e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTEN—uterine cancer	1.08e-05	7.29e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	1.08e-05	7.27e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTEN—uterine cancer	1.08e-05	7.26e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	1.07e-05	7.2e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—uterine cancer	1.07e-05	7.19e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	1.07e-05	7.18e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	1.06e-05	7.14e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTEN—uterine cancer	1.06e-05	7.13e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	1.06e-05	7.12e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTEN—uterine cancer	1.05e-05	7.1e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTEN—uterine cancer	1.05e-05	7.09e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	1.05e-05	7.08e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTEN—uterine cancer	1.05e-05	7.08e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	1.05e-05	7.08e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—uterine cancer	1.05e-05	7.04e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTEN—uterine cancer	1.04e-05	7.01e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	1.04e-05	6.99e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	1.03e-05	6.97e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.03e-05	6.95e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB2—uterine cancer	1.03e-05	6.95e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—EP300—uterine cancer	1.03e-05	6.95e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	1.03e-05	6.93e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EP300—uterine cancer	1.03e-05	6.92e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	1.03e-05	6.91e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—uterine cancer	1.02e-05	6.89e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—uterine cancer	1.02e-05	6.88e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—uterine cancer	1.02e-05	6.86e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—uterine cancer	1.02e-05	6.86e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	1.02e-05	6.85e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	1.02e-05	6.85e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	1.02e-05	6.84e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	1.01e-05	6.82e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—uterine cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—uterine cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EP300—uterine cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EP300—uterine cancer	1.01e-05	6.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EP300—uterine cancer	1.01e-05	6.78e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—EP300—uterine cancer	1e-05	6.76e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EP300—uterine cancer	1e-05	6.75e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—uterine cancer	9.99e-06	6.73e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—uterine cancer	9.99e-06	6.73e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EP300—uterine cancer	9.93e-06	6.69e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EP300—uterine cancer	9.9e-06	6.67e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—uterine cancer	9.79e-06	6.59e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—uterine cancer	9.78e-06	6.59e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	9.74e-06	6.56e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—uterine cancer	9.73e-06	6.55e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—EP300—uterine cancer	9.71e-06	6.54e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—EP300—uterine cancer	9.71e-06	6.54e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—uterine cancer	9.65e-06	6.5e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—uterine cancer	9.62e-06	6.48e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—uterine cancer	9.61e-06	6.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	9.58e-06	6.45e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	9.56e-06	6.44e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	9.56e-06	6.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	9.53e-06	6.42e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	9.5e-06	6.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—uterine cancer	9.47e-06	6.38e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—uterine cancer	9.47e-06	6.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	9.46e-06	6.37e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—uterine cancer	9.44e-06	6.36e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—uterine cancer	9.41e-06	6.34e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—uterine cancer	9.41e-06	6.34e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—uterine cancer	9.41e-06	6.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	9.41e-06	6.33e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—uterine cancer	9.38e-06	6.32e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	9.38e-06	6.32e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—uterine cancer	9.34e-06	6.29e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—uterine cancer	9.34e-06	6.29e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—uterine cancer	9.29e-06	6.26e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—uterine cancer	9.29e-06	6.26e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—uterine cancer	9.29e-06	6.26e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	9.27e-06	6.24e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	9.25e-06	6.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	9.25e-06	6.23e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	9.03e-06	6.08e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—uterine cancer	9.02e-06	6.07e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—uterine cancer	8.89e-06	5.99e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—uterine cancer	8.87e-06	5.97e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—uterine cancer	8.87e-06	5.97e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—uterine cancer	8.8e-06	5.93e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	8.74e-06	5.88e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	8.74e-06	5.88e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—uterine cancer	8.63e-06	5.81e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—uterine cancer	8.6e-06	5.79e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—uterine cancer	8.6e-06	5.79e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—uterine cancer	8.59e-06	5.78e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—uterine cancer	8.58e-06	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—uterine cancer	8.58e-06	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—uterine cancer	8.52e-06	5.74e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—uterine cancer	8.52e-06	5.74e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EP300—uterine cancer	8.4e-06	5.65e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—uterine cancer	8.31e-06	5.6e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—uterine cancer	8.31e-06	5.6e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—uterine cancer	8.28e-06	5.57e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—uterine cancer	8.21e-06	5.53e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	8.14e-06	5.48e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—uterine cancer	8.13e-06	5.47e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EP300—uterine cancer	8.12e-06	5.47e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EP300—uterine cancer	8.12e-06	5.47e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—uterine cancer	8.1e-06	5.46e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—uterine cancer	8.07e-06	5.44e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—uterine cancer	8e-06	5.39e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—uterine cancer	7.98e-06	5.37e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	7.97e-06	5.37e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—uterine cancer	7.95e-06	5.36e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—uterine cancer	7.94e-06	5.35e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—uterine cancer	7.94e-06	5.35e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—uterine cancer	7.85e-06	5.29e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—uterine cancer	7.85e-06	5.29e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—uterine cancer	7.69e-06	5.18e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—uterine cancer	7.69e-06	5.18e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—uterine cancer	7.63e-06	5.14e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—EP300—uterine cancer	7.61e-06	5.12e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	7.6e-06	5.12e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—uterine cancer	7.6e-06	5.12e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—uterine cancer	7.6e-06	5.12e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—uterine cancer	7.59e-06	5.11e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—uterine cancer	7.59e-06	5.11e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—uterine cancer	7.52e-06	5.06e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	7.48e-06	5.04e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	7.47e-06	5.03e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—uterine cancer	7.45e-06	5.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	7.44e-06	5.01e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—uterine cancer	7.43e-06	5e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	7.42e-06	5e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—uterine cancer	7.36e-06	4.95e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	7.35e-06	4.95e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	7.33e-06	4.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—uterine cancer	7.25e-06	4.88e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—uterine cancer	7.25e-06	4.88e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—uterine cancer	7.24e-06	4.87e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—uterine cancer	7.22e-06	4.86e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—uterine cancer	7.2e-06	4.85e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—uterine cancer	7.19e-06	4.84e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—uterine cancer	7.19e-06	4.84e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—uterine cancer	7.18e-06	4.83e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—EP300—uterine cancer	7.17e-06	4.83e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—EP300—uterine cancer	7.11e-06	4.79e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—uterine cancer	7.11e-06	4.79e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—uterine cancer	7.09e-06	4.77e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—uterine cancer	7.04e-06	4.74e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—uterine cancer	7.01e-06	4.72e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—uterine cancer	7.01e-06	4.72e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	6.92e-06	4.66e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—uterine cancer	6.91e-06	4.65e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—uterine cancer	6.89e-06	4.64e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—uterine cancer	6.86e-06	4.62e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—uterine cancer	6.8e-06	4.58e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	6.78e-06	4.56e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—uterine cancer	6.76e-06	4.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—uterine cancer	6.54e-06	4.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—uterine cancer	6.54e-06	4.4e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—uterine cancer	6.23e-06	4.2e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—uterine cancer	6.21e-06	4.18e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	6.21e-06	4.18e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	6.11e-06	4.12e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—uterine cancer	6.1e-06	4.11e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—uterine cancer	6.08e-06	4.09e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—uterine cancer	6.07e-06	4.09e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—uterine cancer	6.06e-06	4.08e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—uterine cancer	6.01e-06	4.05e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	6.01e-06	4.05e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	6.01e-06	4.05e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—uterine cancer	6e-06	4.04e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	5.98e-06	4.03e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—uterine cancer	5.87e-06	3.95e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—uterine cancer	5.87e-06	3.95e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—uterine cancer	5.81e-06	3.91e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—uterine cancer	5.81e-06	3.91e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—uterine cancer	5.75e-06	3.87e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—uterine cancer	5.63e-06	3.79e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—uterine cancer	5.56e-06	3.74e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—uterine cancer	5.56e-06	3.74e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	5.3e-06	3.57e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—uterine cancer	5.26e-06	3.54e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—uterine cancer	5.07e-06	3.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—uterine cancer	4.91e-06	3.31e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—uterine cancer	4.91e-06	3.31e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—uterine cancer	4.6e-06	3.1e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—uterine cancer	4.33e-06	2.92e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—uterine cancer	4.3e-06	2.89e-05	CbGpPWpGaD
